AKBA
Akebia Therapeutics Inc
Price:  
1.47 
USD
Volume:  
3,010,500.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Stock Forecast & Price Target

AKBA Stock Price Forecast

The average stock forecast for Akebia Therapeutics Inc (AKBA) in the next 12 months is 5.10 USD. This price target corresponds to an upside of 246.94%. The range of stock forecasts for AKBA is 4.04 - 6.30 USD. Based on the ratings of 9 analysts, the consensus recommendation for AKBA is BUY.
Target Low Average Median High
Price (USD) 4.04 5.10 5.10 6.30
Upside 174.83% 246.94% 246.94% 328.57%

Recommendation Trends

The latest consensus rating for AKBA is "BUY". This is the average recommendation of 9 analysts: 0 strong sell, 0 sell, 1 hold, 5 buy, 3 strong buy. In the previous period, 9 analysts also majorly recommmended "BUY" for AKBA.

AKBA Financial Stock Forecast

Revenue This Year
172.53M
-11.35%
from 194.62M
Revenue Next Year
159.38M
-7.62%
from 172.53M
EPS This Year
-0.30
20.95%
from -0.25
EPS Next Year
-0.33
10.11%
from -0.30